Clinical Trial Update: Prevention of Postpartum Hemorrhage With TXA [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating tranexamic acid (TXA) for prevention of postpartum hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• TXA (tranexamic acid)

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Postpartum Hemorrhage | Phase 4 | Status: WITHDRAWN